16:02 Dec 20
Jubilant Pharmova Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Jubilant Pharmova Ltd.
68/100 High Financial Strength
Quality61/100 Affordable Valuation
Valuation53/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
4
Opportunity
1
Threat
0
16.91K
Market Cap (Cr)
28.51
PE Ratio
2.85
Price to Book Ratio
35.18
RSI
1.15 %
Net Profit Margin
SWOT
Download Our App On:
